Michael Bates

Mike Bates is Co-Head of the Life Science Screening Committee at the Band of Angels and an active member of the Life Science Angels. He has invested in over 30 startups, about two-thirds of which are medical technology related. His portfolio includes companies such as Practice Fusion, HealthCrowd, CogENT Therapeutics, Aerin Medical and Mixbook.com. He formerly served as Director and Audit Committee Chairman of BÂRRX Medical, Emphasys Medical, and Satiety. He also served as a Director of Catheter Connections, Inc., a company seed funded by Life Science Angels. Prior to becoming an angel investor, Mr. Bates served as Chief Financial Officer of four successful life science companies, all of which were sold at premium valuations generating high rates of return for their investors, including St. Francis Medical Technologies, Inc. (sold to Kyphon in January 2007), Silicon Genetics (sold to Agilent Technologies in 2004), Collagen Aesthetics, Inc. (sold to Inamed in 1999) and Penederm Incorporated (sold to Mylan Laboratories in 1998). Mr. Bates is a certified public accountant (non-practicing), having begun his career at Deloitte LLP and has also held positions at Tandem Computers Inc. He is a graduate of California State University, East Bay and received an MBA in Finance from the University of California at Berkeley.